Find a story
Search Spins
Search titles, summaries, and missing voices across published articles — press releases, announcements, and media coverage.
6 results for “GeneDx”
GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS
A securities class action lawsuit has been filed against GeneDx Holdings Corp. (WGS), and investors with losses exceeding $100,000 have until August 3, 2026 to apply for lead plaintiff status.
Jul 25, 2026
WGS Deadline: WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit
A law firm issued a press release notifying investors of GeneDx Holdings Corp. (NASDAQ: WGS) shareholders about an upcoming deadline to apply for lead plaintiff status in a pending securities fraud class action lawsuit.
Jul 18, 2026
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
A securities fraud class action lawsuit has been filed against GeneDx Holdings alleging misrepresentations about acquisition performance that contributed to a 49% stock decline.
Jul 18, 2026
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit
A law firm is notifying investors of GeneDx Holdings Corp. (WGS) that they may join or lead a securities fraud class-action lawsuit related to alleged misrepresentations during a defined trading period.
Jul 13, 2026
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
A securities fraud class action lawsuit has been filed against GeneDx Holdings alleging misrepresentations about acquisition performance that contributed to a 49% stock decline.
Published Jul 4, 2026 · Analyzed Jul 6, 2026
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit
A law firm is soliciting investors to join a securities fraud class-action lawsuit against GeneDx Holdings Corp., alleging material misrepresentations or omissions during a defined trading period.
Published Jul 2, 2026 · Analyzed Jul 5, 2026